What is the recommended timeline for the Tdap (tetanus, diphtheria, and pertussis) vaccine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Tdap Vaccine Timeline Recommendations

The Tdap vaccine should be administered as a single dose at age 11-12 years, with booster doses of either Td or Tdap every 10 years throughout life, and pregnant women should receive one dose during each pregnancy at 27-36 weeks gestation regardless of prior vaccination history. 1, 2

Age-Specific Tdap Vaccination Schedule

Children Under 7 Years

  • Primary series with DTaP (not Tdap) at:
    • 2 months
    • 4 months
    • 6 months
    • 15-18 months
    • 4-6 years 1, 2

Adolescents (11-18 years)

  • Single dose of Tdap at age 11-12 years, regardless of previous vaccination history
  • Booster doses of either Td or Tdap every 10 years thereafter 1
  • If Tdap was inadvertently given to a child aged 7-10 years, the adolescent Tdap dose should still be administered at age 11-12 years 2

Adults (≥19 years)

  • One-time dose of Tdap for those who have never received it, regardless of interval since last tetanus-containing vaccine
  • Booster doses of either Td or Tdap every 10 years thereafter 1

Pregnant Women

  • One dose of Tdap during each pregnancy at 27-36 weeks gestation (preferably earlier in this window)
  • This recommendation applies regardless of prior Tdap vaccination history 1, 2
  • Studies show this strategy provides 77.7% effectiveness in preventing pertussis in infants under 2 months of age 3

Catch-up Vaccination Schedules

For Persons Aged 7-18 Years Not Fully Immunized

  1. First dose: Tdap
  2. Second dose: Either Td or Tdap ≥4 weeks after first dose
  3. Third dose: Either Td or Tdap 6-12 months after second dose 1

For Adults (≥19 Years) Never Vaccinated

  1. First dose: Tdap
  2. Second dose: Either Td or Tdap ≥4 weeks after first dose
  3. Third dose: Either Td or Tdap 6-12 months after second dose 1

Tetanus Prophylaxis for Wound Management

  • A tetanus toxoid-containing vaccine is indicated when >5 years have passed since the last dose
  • For persons ≥11 years without prior Tdap or unknown history: Use Tdap
  • For pregnant women: Use Tdap
  • For persons with documented prior Tdap: Either Td or Tdap may be used 1

Important Clinical Considerations

  • The vaccination series does not need to be restarted regardless of time elapsed between doses 1, 2
  • A fifth DTaP dose is not necessary if the fourth dose was administered at age ≥4 years 1
  • For adults, Tdap administration should not be delayed and can be given regardless of interval since the last tetanus-containing vaccine 1

Common Pitfalls to Avoid

  1. Delaying Tdap in adolescents: This leaves them vulnerable to pertussis during a high-risk period 2
  2. Missing pregnant women: Each pregnancy requires Tdap vaccination regardless of prior history 1
  3. Restarting vaccination series: The series never needs to be restarted, regardless of time elapsed between doses 1, 2
  4. Waiting 10 years after childhood DTaP: Adolescents need Tdap at 11-12 years even if less than 10 years have passed since their last DTaP 1
  5. Overlooking wound management: Tetanus prophylaxis is needed when >5 years have passed since the last tetanus-containing vaccine 1

By following these guidelines, healthcare providers can ensure optimal protection against tetanus, diphtheria, and pertussis across all age groups, with special attention to protecting vulnerable infants through maternal vaccination.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Vaccination Guidelines for Tetanus, Diphtheria, and Pertussis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Impact of the US Maternal Tetanus, Diphtheria, and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants <2 Months of Age: A Case-Control Evaluation.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.